Why The CDC May Look Very Different In Trump's 2nd Term
As the healthcare industry braces for significant policy changes under a second Trump administration, some experts say the Centers for Disease Control and Prevention could see the most significant alterations both in mission and structure, in part because of the agency's unique, and vulnerable, position under the law.
.jpg)
Wash. Ballot Win Gives States Blueprint For 'Age Wave' Care
Washington's first-in-the-nation program to provide long-term care insurance backed by a payroll tax won a decisive victory at the polls last week, offering a potential model for other states as baby boomers age out of the workforce and more families seek eldercare.
3rd Circ. Shuts Down Healthcare Workers' Vax Bias Suit
A split Third Circuit panel said a group of Christian workers can't revive suits claiming a healthcare provider illegally fired them for refusing the COVID-19 vaccine on religious grounds, finding they failed to show how their beliefs prevented them from getting immunized.
Why The CDC May Look Very Different In Trump's 2nd Term
As the healthcare industry braces for significant policy changes under a second Trump administration, some experts say the Centers for Disease Control and Prevention could see the most significant alterations both in mission and structure, in part because of the agency's unique, and vulnerable, position under the law.
Wash. Ballot Win Gives States Blueprint For 'Age Wave' Care
Washington's first-in-the-nation program to provide long-term care insurance backed by a payroll tax won a decisive victory at the polls last week, offering a potential model for other states as baby boomers age out of the workforce and more families seek eldercare.
Expert Analysis
Despite the nationwide injunction against the Federal Trade Commission’s noncompete ban, and the incoming Republic... (more story)
As the legislative and oversight agendas of the 119th Congress come into sharper focus, corporate counsel should a... (more story)
Though President-elect Donald Trump has not yet articulated policy priorities regarding the life sciences industry... (more story)
Deals & Corporate Governance More
A drugmaker that recently sold a manufacturing facility to Eli Lilly for nearly $1 billion has failed to persuade a federal judge in Chicago to wipe out patents covering a line of injections that treat infecti... (more story)
A medical device trade group has said the U.S. Supreme Court should take up an appeal of a Federal Circuit decision Edwards Lifesciences said broadened a drug-development safe harbor to avoid patent infringeme... (more story)
CVS Health, represented by Wachtell Lipton Rosen & Katz, said Monday it has struck a deal with activist investor Glenview Capital Management to appoint four new board members, including Glenview CEO Larry Robbins.
Morgan Lewis & Bockius LLP announced that an experienced litigator from Orrick Herrington & Sutcliffe LLP joined the firm's Boston office as a partner, enhancing its capacity in areas such as life sciences and... (more story)
In this week's Taxation With Representation, Cardinal Health takes a majority stake in GI Alliance and acquires Advanced Diabetes Supply Group, Just Eat offloads Grubhub to Wonder Group, Rivian Automotive and ... (more story)
A group of emergency clinic medical providers objected to the $2.8 billion settlement a broader class of medical providers reached with the Blue Cross Blue Shield network of insurers last month, as attorneys f... (more story)
Digital Health & Technology More
A Connecticut federal judge awarded $340,000 on Monday to class counsel in a data breach lawsuit against Merritt Healthcare Advisors but criticized their request for $381,250 as out of line with reasonable rat... (more story)
Connecticut-based genetic testing company GeneDx announced Monday that an experienced in-house healthcare attorney who most recently worked as general counsel at Zoetis was named its chief legal officer and co... (more story)
Thompson Coburn LLP was hit with a proposed class action Tuesday in Missouri federal court alleging the firm did not do enough to safeguard data provided to a healthcare provider client, resulting in a data br... (more story)
California-based Included Health, which calls itself an "all-in-one" healthcare solution, announced Tuesday that it has snagged the former legal head at Oak Street Health as its new chief legal officer.
A retired Apple executive defended the tech giant Friday in Masimo's trade secret suit over pulse oximetry technology, testifying in California federal court that Apple didn't hire a Masimo spinoff's chief tec... (more story)
Cercacor Laboratories' former chief technology officer testified Thursday that he privately emailed Apple CEO Tim Cook offering to help the tech giant become a top health and wellness device brand, but denied ... (more story)
Policy & Compliance More
Eli Lilly & Co. claims the U.S. Department of Health and Human Services is unlawfully blocking its efforts to crack down on hospitals the company alleges are double-dipping on medication discounts that are mea... (more story)
A California federal judge indicated Friday that she can't force the U.S. Department of Health and Human Services to provide human rights groups with regular data about children in low-security detention facil... (more story)
The Federal Trade Commission's allegations that pharmacy benefit manager giants Caremark Rx, Express Scripts and OptumRx are artificially inflating insulin prices through unfair rebate schemes will forge ahead... (more story)
Robert F. Kennedy Jr., President-elect Donald Trump's pick to be the nation's top health official, has made clear his unorthodox and often false views on public health issues like vaccines. But there's still p... (more story)
Two telehealth companies misclassified account managers and client relations directors as overtime-exempt despite their job duties not qualifying for any of the exemptions under the Fair Labor Standards Act, a... (more story)
Teva Pharmaceuticals has asked a California federal judge to reject a bid to dismiss its lawsuit against the maker of a brand-name drug used to treat a rare cortisol disorder, contending its complaint plausibl... (more story)